05/28/2026
Is shoulder surgery superior to physical therapy? Find out in this captivating study:
https://www.facebook.com/share/1952cPTGid/?mibextid=wwXIfr
๐ง๐ต๐ฒ ๐ญ๐ฌ-๐ฌ๐ฒ๐ฎ๐ฟ ๐ฉ๐ฒ๐ฟ๐ฑ๐ถ๐ฐ๐ ๐ผ๐ป ๐ฆ๐ต๐ผ๐๐น๐ฑ๐ฒ๐ฟ ๐ฆ๐๐ฟ๐ด๐ฒ๐ฟ๐: ๐๐ ๐๐ ๐๐๐๐ ๐ฎ ๐ฃ๐น๐ฎ๐ฐ๐ฒ๐ฏ๐ผ?
โผ๏ธ Arthroscopic subacromial decompression (ASD) is one of the most common orthopaedic procedures globally, with nearly 30,000 of these surgeries performed annually for shoulder pain in England alone.
โผ๏ธ Since 2007-2008, the cumulative cost of ASD surgeries to the NHS has surpassed ยฃ1 billion.
โผ๏ธ However, a groundbreaking 10-year follow-up study from the FIMPACT trial has delivered a clear and startling verdict: this popular shoulder surgery offers no meaningful long-term clinical benefits compared to a placebo surgery or simple exercise therapy.
๐ง๐ต๐ฒ ๐๐๐ ๐ฃ๐๐๐ง ๐ง๐ฟ๐ถ๐ฎ๐น ๐ฆ๐๐ฟ๐๐ฐ๐๐๐ฟ๐ฒ ๐ฌ
โผ๏ธ The Finnish Subacromial Impingement Arthroscopy Controlled Trial (FIMPACT) was a rigorous, multicenter, randomized trial designed to test whether ASD actually works.
โผ๏ธ The study involved 210 adults, aged 35 to 65, who had suffered from subacromial pain syndrome for over three months without finding relief from non-operative treatments.
โผ๏ธ Patients with full-thickness rotator cuff tears or osteoarthritis were excluded to ensure the data was highly specific to subacromial pain syndrome.
๐ฃ๐ฎ๐ฟ๐๐ถ๐ฐ๐ถ๐ฝ๐ฎ๐ป๐๐ ๐๐ฒ๐ฟ๐ฒ ๐ฟ๐ฎ๐ป๐ฑ๐ผ๐บ๐น๐ ๐ฎ๐๐๐ถ๐ด๐ป๐ฒ๐ฑ ๐๐ผ ๐ผ๐ป๐ฒ ๐ผ๐ณ ๐๐ต๐ฟ๐ฒ๐ฒ ๐ด๐ฟ๐ผ๐๐ฝ๐: ๐
โผ๏ธ The Surgery Group: Received standard arthroscopic subacromial decompression.
โผ๏ธ The Placebo Group: Underwent a diagnostic arthroscopy, meaning doctors looked inside the shoulder with a camera but terminated the operation without performing the actual decompression.
โผ๏ธ The Exercise Group: Completed a progressive, individually tailored physiotherapy program supervised by specially trained physiotherapists.
โผ๏ธ Both the patients and the individuals collecting the data were blinded to who received the real surgery and who received the placebo.
โผ๏ธ Impressively, 87% of the participants completed the full 10-year follow-up.
๐ง๐ต๐ฒ ๐ญ๐ฌ-๐ฌ๐ฒ๐ฎ๐ฟ ๐ฅ๐ฒ๐๐๐น๐๐: ๐๐๐ฒ๐ฟ๐๐ผ๐ป๐ฒ ๐๐ผ๐ ๐๐ฒ๐๐๐ฒ๐ฟ, ๐๐๐ ๐ฆ๐๐ฟ๐ด๐ฒ๐ฟ๐ ๐๐ถ๐ฑ๐ปโ๐ ๐ ๐ฎ๐๐๐ฒ๐ฟ ๐
โผ๏ธ After a decade of follow-up, the results yielded a surprising conclusion: all three treatment groups experienced substantial and sustained improvements in shoulder pain and function.
โผ๏ธ Most of this healing occurred within the first five years and was maintained through year ten.
โผ๏ธ However, when comparing the outcomes between the groups, the researchers found that the actual surgery provided absolutely no clinical advantage.
๐ฆ๐ฝ๐ฒ๐ฐ๐ถ๐ณ๐ถ๐ฐ๐ฎ๐น๐น๐: โ ๏ธ
โผ๏ธ No Difference from Placebo: There were no significant differences between the ASD group and the placebo surgery group regarding shoulder pain at rest or during arm activity.
โผ๏ธ No Difference from Exercise: The surgery group also did not experience better outcomes than the group that only performed exercise therapy.
โผ๏ธ Secondary Outcomes: Measurements for overall health-related quality of life, patient satisfaction, and shoulder function also showed no significant differences between the groups.
๐ง๐ต๐ฒ ๐ฃ๐ฟ๐ผ๐ฏ๐น๐ฒ๐บ ๐ผ๐ณ โ๐ ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐ฅ๐ฒ๐๐ฒ๐ฟ๐๐ฎ๐นโ ๐
โผ๏ธ Prior to this 10-year follow-up, eight different randomized controlled trials had already demonstrated that ASD provided no short- or medium-term advantages over placebo surgery or non-surgical management.
โผ๏ธ This new 10-year data decisively resolves any lingering clinical uncertainty, confirming that there are no hidden long-term benefits either.
โผ๏ธ Yet, ASD remains widely endorsed in certain clinical practice guidelines and is frequently performed worldwide.
โผ๏ธ The authors of the study highlight this as a classic example of โmedical reversalโโa phenomenon where a medical procedure persists despite rigorous evidence proving it is ineffective.
โผ๏ธ The researchers note that the continuation of this surgery is likely sustained by entrenched professional beliefs, institutional inertia, and financial incentives.
๐ง๐ต๐ฒ ๐ง๐ฎ๐ธ๐ฒ๐ฎ๐๐ฎ๐ ๐ฉบ
โผ๏ธ The implications of this 10-year study are profound for both healthcare providers and patients.
โผ๏ธ The researchers strongly conclude that ASD should not be offered to patients outside of rigorously designed clinical trials.
โผ๏ธ Instead, a concerted effort toward โde-implementationโ is necessary in routine care.
โผ๏ธ Moving forward, health systems, doctors, and patients should abandon this ineffective surgical route and prioritize adopting less burdensome, non-operative treatments like exercise therapy to manage subacromial shoulder pain.